Healthcare · Managed Health Care

Elevance Health, Inc.

NYSEELV ISINUS0367521038 SEC CIK0001156039 Listed on NYSE · USD

$431.45 +1.97 (+0.46%) After hours $427.00 (-1.03%) ≈ ₹40,492 a share

Open chart

Price, last 12 months+35.15% in a year

Key numbers

Market value: $93.22B
P/E (TTM): 18.4
Forward P/E: 15.8
EPS (TTM): $23.46
Dividend yield: 1.59%
Beta: 0.62
Day range: $427.13 – $435.00
52-week range: $274.84 – $450.69
Volume: 208,827
10-day avg volume: $1.37M
Revenue (TTM): $201.83B
EBITDA (TTM): $10.33B
Gross margin: —
Net margin: 2.5%
Return on equity: 11.6%
Debt / equity: 68.8%
Price / sales: 0.46
Shares out: 216.06M

52W low52W high

Quarterly results

Results for each quarter

Last 12 quarters from 10-Q and 10-K filings with the US SEC. Q4 = full year minus the first three quarters. Hover a bar to see the number.

Revenue and net income

$42.65B$1.28B$856.00M

Dec 23

$42.58B$3.02B$2.25B

Mar 24

$43.89B$2.77B$2.30B

Jun 24

$45.11B$1.41B$1.02B

Sep 24

$45.44B$673.00M$418.00M

Dec 24

$48.89B$3.17B$2.18B

Mar 25

$49.78B$2.43B$1.74B

Jun 25

$50.71B$1.30B$1.19B

Sep 25

$49.75B$309.00M$547.00M

Dec 25

$50.18B$2.09B$1.76B

Mar 26

$50.47B$1.76B$1.46B

Jun 26

$51.43B$1.27B$1.37B

Sep 26

Revenue · QoQ (vs last quarter)

—-0.2%+3.1%+2.8%+0.7%+7.6%+1.8%+1.9%-1.9%+0.9%+0.6%+1.9%

Revenue · YoY (vs a year ago)

————+6.6%+15%+13%+12%+9.5%+2.6%+1.4%+1.4%

Net income · QoQ (vs last quarter)

—+162%+2.4%-56%-59%+422%-20%-32%-54%+222%-17%-6.7%

Net income · YoY (vs a year ago)

————-51%-2.8%-24%+17%+31%-19%-16%+15%

RevenueOperating incomeNet incomeLine = trend

US$	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	$42.65B	$42.58B	$43.89B	$45.11B	$45.44B	$48.89B	$49.78B	$50.71B	$49.75B	$50.18B	$50.47B	$51.43B
Cost of revenue	$4.84B	$3.83B	$4.82B	$5.09B	$6.01B	$4.98B	$5.29B	$5.38B	$5.52B	$5.46B	$5.49B	$5.64B
Gross profit	$37.81B	$38.75B	$39.07B	$40.01B	$39.43B	$43.91B	$44.48B	$45.33B	$44.23B	$44.72B	$44.98B	$45.79B
Gross margin	88.7%	91.0%	89.0%	88.7%	86.8%	89.8%	89.4%	89.4%	88.9%	89.1%	89.1%	89.0%
Selling, general & admin	$5.00B	$4.89B	$5.07B	$5.27B	$4.80B	$5.30B	$5.00B	$5.27B	$5.42B	$6.33B	$5.55B	$5.75B
Operating income	$1.28B	$3.02B	$2.77B	$1.41B	$673.00M	$3.17B	$2.43B	$1.30B	$309.00M	$2.09B	$1.76B	$1.27B
Operating margin	3.0%	7.1%	6.3%	3.1%	1.5%	6.5%	4.9%	2.6%	0.6%	4.2%	3.5%	2.5%
Interest expense	$259.00M	$265.00M	$280.00M	$300.00M	$340.00M	$344.00M	$341.00M	$351.00M	$366.00M	$357.00M	$364.00M	$358.00M
Pre-tax income	$1.00B	$2.94B	$2.99B	$1.37B	$606.00M	$2.80B	$2.29B	$1.41B	$215.00M	$2.30B	$1.94B	$1.79B
Income tax	$170.00M	$690.00M	$685.00M	$365.00M	$193.00M	$613.00M	$548.00M	$219.00M	$-331.00M	$544.00M	$483.00M	$451.00M
Net income	$856.00M	$2.25B	$2.30B	$1.02B	$418.00M	$2.18B	$1.74B	$1.19B	$547.00M	$1.76B	$1.46B	$1.37B
Net margin	2.0%	5.3%	5.2%	2.3%	0.9%	4.5%	3.5%	2.3%	1.1%	3.5%	2.9%	2.7%
EPS (diluted)	—	$9.59	$9.85	$4.36	—	$9.61	$7.72	$5.32	—	$8.00	$6.71	$6.27

Income statement

Results for each year

8 fiscal years from the company's 10-K filings with the US SEC.

Revenue, gross profit and net income

$92.11B$92.11B$3.75B

FY18

$104.21B$102.22B$4.81B

FY19

$121.87B$112.91B$4.57B

FY20

$138.64B$127.74B$6.16B

FY21

$156.60B$143.56B$5.89B

FY22

$171.34B$154.05B$5.99B

FY23

$177.01B$157.26B$5.98B

FY24

$199.13B$177.95B$5.66B

FY25

Revenue · YoY (vs a year ago)

—+13%+17%+14%+13%+9.4%+3.3%+12%

Net income · YoY (vs a year ago)

—+28%-4.9%+35%-4.3%+1.6%-0.1%-5.3%

RevenueGross profitNet incomeLine = trend

$14.19

FY18

$18.47

FY19

$17.98

FY20

$24.95

FY21

$24.28

FY22

$25.22

FY23

$25.68

FY24

$25.21

FY25

EPS (diluted) · YoY (vs a year ago)

—+30%-2.7%+39%-2.7%+3.9%+1.8%-1.8%

EPS (diluted)Line = trend

US$	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$92.11B	$104.21B	$121.87B	$138.64B	$156.60B	$171.34B	$177.01B	$199.13B
Revenue growth	—	13.1%	16.9%	13.8%	13.0%	9.4%	3.3%	12.5%
Cost of revenue	$0	$1.99B	$8.95B	$10.90B	$13.04B	$17.29B	$19.75B	$21.18B
Gross profit	$92.11B	$102.22B	$112.91B	$127.74B	$143.56B	$154.05B	$157.26B	$177.95B
Gross margin	100.0%	98.1%	92.7%	92.1%	91.7%	89.9%	88.8%	89.4%
Selling, general & admin	$14.02B	$13.36B	$17.45B	$15.92B	$17.70B	$20.09B	$20.03B	$20.98B
Operating income	$5.43B	$6.00B	$6.36B	$7.56B	$8.28B	$8.50B	$7.86B	$7.20B
Operating margin	5.9%	5.8%	5.2%	5.5%	5.3%	5.0%	4.4%	3.6%
Depreciation & amortisation	$1.13B	$1.13B	$1.15B	$1.30B	$1.68B	$1.75B	$1.39B	$1.55B
Interest expense	$753.00M	$746.00M	$784.00M	$798.00M	$851.00M	$1.03B	$1.19B	$1.40B
Pre-tax income	$5.07B	$5.99B	$6.24B	$8.00B	$7.60B	$7.72B	$7.90B	$6.71B
Income tax	$1.32B	$1.18B	$1.67B	$1.85B	$1.71B	$1.72B	$1.93B	$1.05B
Tax rate	26.0%	19.7%	26.7%	23.1%	22.5%	22.3%	24.5%	15.6%
Net income	$3.75B	$4.81B	$4.57B	$6.16B	$5.89B	$5.99B	$5.98B	$5.66B
Net margin	4.1%	4.6%	3.8%	4.4%	3.8%	3.5%	3.4%	2.8%
EPS (diluted)	$14.19	$18.47	$17.98	$24.95	$24.28	$25.22	$25.68	$25.21

Balance sheet

Assets and debt

At each fiscal year end.

Equity, debt and cash

$28.54B$18.07B$20.63B

FY18

$31.73B$19.39B$24.61B

FY19

$33.20B$20.04B$29.17B

FY20

$36.10B$22.76B$31.15B

FY21

$36.24B$23.85B$33.34B

FY22

$39.31B$24.90B$36.14B

FY23

$41.32B$30.87B$33.49B

FY24

$43.88B$31.90B$35.38B

FY25

Shareholders' equity · YoY (vs a year ago)

—+11%+4.6%+8.7%+0.4%+8.5%+5.1%+6.2%

Shareholders' equityTotal debtCash + short-term investmentsLine = trend

US$	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & equivalents	$3.93B	$4.94B	$5.74B	$4.88B	$7.39B	$6.53B	$8.29B	$9.49B
Short-term investments	$16.69B	$19.68B	$23.43B	$26.27B	$25.95B	$29.61B	$25.20B	$25.88B
Current assets	$34.32B	$39.03B	$45.75B	$51.12B	$55.62B	$60.03B	$58.94B	$63.00B
Total assets	$71.57B	$77.45B	$86.62B	$97.46B	$102.76B	$108.93B	$116.89B	$121.49B
Current liabilities	$21.97B	$23.53B	$29.45B	$34.89B	$39.70B	$41.79B	$40.58B	$41.04B
Long-term debt	$17.22B	$17.79B	$19.34B	$21.16B	$22.35B	$23.25B	$29.22B	$30.80B
Short-term debt	$849.00M	$1.60B	$700.00M	$1.60B	$1.50B	$1.65B	$1.65B	$1.10B
Total debt	$18.07B	$19.39B	$20.04B	$22.76B	$23.85B	$24.90B	$30.87B	$31.90B
Total liabilities	$43.03B	$45.73B	$53.42B	$61.29B	$66.43B	$69.52B	$75.46B	$77.47B
Shareholders' equity	$28.54B	$31.73B	$33.20B	$36.10B	$36.24B	$39.31B	$41.32B	$43.88B
Current ratio	1.56	1.66	1.55	1.47	1.40	1.44	1.45	1.54
Debt / equity	0.63	0.61	0.60	0.63	0.66	0.63	0.75	0.73
Return on equity	13.1%	15.2%	13.8%	17.1%	16.3%	15.2%	14.5%	12.9%

Cash flow

Cash coming in and going out

Free cash flow = cash from operations minus capital spending. Shareholder returns = dividends + buybacks.

Free cash flow and shareholder returns

$3.83B$2.62B$2.46B

FY18

$6.06B$4.98B$2.52B

FY19

$10.69B$9.67B$3.65B

FY20

$8.36B$7.28B$3.00B

FY21

$8.40B$7.25B$3.55B

FY22

$8.06B$6.77B$4.07B

FY23

$5.81B$4.55B$4.41B

FY24

$4.29B$3.17B$4.13B

FY25

Operating cash flow · YoY (vs a year ago)

—+58%+76%-22%+0.4%-4.0%-28%-26%

Free cash flow · YoY (vs a year ago)

—+90%+94%-25%-0.4%-6.7%-33%-30%

Operating cash flowFree cash flowDividends + buybacksLine = trend

US$	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash from operations	$3.83B	$6.06B	$10.69B	$8.36B	$8.40B	$8.06B	$5.81B	$4.29B
Capital spending	$-1.21B	$-1.08B	$-1.02B	$-1.09B	$-1.15B	$-1.30B	$-1.26B	$-1.12B
Free cash flow	$2.62B	$4.98B	$9.67B	$7.28B	$7.25B	$6.77B	$4.55B	$3.17B
FCF margin	2.8%	4.8%	7.9%	5.2%	4.6%	3.9%	2.6%	1.6%
Stock-based pay	$226.00M	$294.00M	$283.00M	$255.00M	$264.00M	$289.00M	$191.00M	$276.00M
Cash from investing	$-1.26B	$-2.79B	$-7.32B	$-9.64B	$-4.56B	$-5.57B	$-5.17B	$-1.34B
Cash from financing	$-2.24B	$-2.27B	$-2.57B	$423.00M	$-1.32B	$-3.35B	$1.19B	$-1.74B
Dividends paid	$-776.00M	$-818.00M	$-954.00M	$-1.10B	$-1.23B	$-1.40B	$-1.51B	$-1.53B
Share buybacks	$-1.69B	$-1.70B	$-2.70B	$-1.90B	$-2.32B	$-2.68B	$-2.90B	$-2.61B

About

About Elevance Health, Inc.

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

From Wikipedia (CC BY-SA 4.0).

Company details

Company name: Elevance Health, Inc.
Ticker: ELV
Exchange: NYSE
ISIN: US0367521038
SEC CIK: 0001156039
Sector: Healthcare
Industry: Managed Health Care
SEC industry (SIC): Hospital & Medical Service Plans (6324)
Incorporated in: Indiana
Financial year ends: 31 December
Filer type: Large accelerated filer
Latest annual report (10-K): 6 Feb 2026
CEO: Gail Boudreaux
Chair: Ramiro G. Peru
Headquarters: Indianapolis
Address: 220 Virginia Avenue, Indianapolis, In 46204
Founded: 1940
Employees: 97,100
Formerly known as: Anthem, Inc., Wellpoint, Inc
Trades in: US dollars (USD)
Website: elevancehealth.com

News

Peers

Others in Healthcare

Quotes from CNBC (may be delayed), financials from SEC EDGAR, profile from global-stock-logos (MIT). Information only, not investment advice.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Elevance Health, Inc.

Key numbers

Quarterly results

Revenue and net income

Income statement

Revenue, gross profit and net income

Balance sheet

Equity, debt and cash

Cash flow

Free cash flow and shareholder returns

About

Company details

News

Peers